PNC Financial Services Group’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9K | Buy |
1,347
+1,037
| +335% | +$9.95K | ﹤0.01% | 3763 |
|
|
2025
Q1 | $1.94K | Buy |
310
+37
| +14% | +$232 | ﹤0.01% | 4353 |
|
|
2024
Q4 | $2.22K | Hold |
273
| – | – | ﹤0.01% | 4254 |
|
|
2024
Q3 | $4.94K | Buy |
273
+122
| +81% | +$2.21K | ﹤0.01% | 4043 |
|
|
2024
Q2 | $1.56K | Sell |
151
-15
| -9% | -$154 | ﹤0.01% | 4321 |
|
|
2024
Q1 | $1.76K | Buy |
166
+31
| +23% | +$329 | ﹤0.01% | 4230 |
|
|
2023
Q4 | $1.23K | Buy |
135
+5
| +4% | +$46 | ﹤0.01% | 4280 |
|
|
2023
Q3 | $1.35K | Buy |
+130
| New | +$1.35K | ﹤0.01% | 4320 |
|
|
2020
Q4 | – | Sell |
-85
| Closed | -$3K | – | 4043 |
|
|
2020
Q3 | $3K | Hold |
85
| – | – | ﹤0.01% | 3765 |
|
|
2020
Q2 | $3K | Hold |
85
| – | – | ﹤0.01% | 3727 |
|
|
2020
Q1 | $2K | Hold |
85
| – | – | ﹤0.01% | 3743 |
|
|
2019
Q4 | $3K | Buy |
+85
| New | +$3K | ﹤0.01% | 3738 |
|